Changes in chemosensory perception, food preferences and emotional responses to foods in cancer patients during the early stages of chemotherapy: an exploratory study
Jaclyn Di Meglio(University of Florence), Sara Spinelli(Eni (Italy)), Giandomenico Roviello(University of Florence), Laura Doni(Azienda Ospedaliero-Universitaria Careggi), Luca Visani(Azienda Ospedaliero-Universitaria Careggi), Caterina Dinnella, Franceso Stingo(University of Florence), L. Antonuzzo(Azienda Ospedaliero-Universitaria Careggi), Paola Tiberio(Fondazione IRCCS Istituto Nazionale dei Tumori), I. Meattini(Azienda Ospedaliero-Universitaria Careggi), Alfredo Guarino(Federico II University Hospital), Erminio Monteleone(University of Florence), Elisabetta Gambale(University of Siena), C. Rorandelli(University of Florence), Vieri Scotti(University of Florence), R. Gerosa(Humanitas University), Rita De Sanctis(Humanitas University)
Cited by 2
Related Papers
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
Challenges in Using Circulating miRNAs as Cancer Biomarkers
|BioMed Research International|2015|264
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
|The Lancet Neurology|2021|260
Functional changes in Duchenne muscular dystrophy
|Neurology|2011|178